Nova Patents
AT292972T

Serine proteinase inhibitory activity by hydrophobic tetracycline

Abstract

(57) It includes medicating this system with hydrophobic 4* (dimethylamino) tetracycline of the amount of serine proteinase prevention as a method of checking the activity of the serine proteinase in a summary biological system. By the method, the organization collapse in the case of the inflammation produced by the activity of human-leukocytes elastase is reduced. The method is used pharmacologically or in makeup study.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

21 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
81655197United States of AmericaA
9803782United States of AmericaW

Members21

Family members, oldest first
DocumentOfficeKind
US5773430AUnited States of AmericaA
CA2283071A1CanadaA1
WO9840079A1World Intellectual Property Organization (WIPO)A1
AU6669898AAustraliaA
EP0975349A1European Patent Office (EPO)A1
KR20000076231ARepublic of KoreaA
AU733308B2AustraliaB2
NZ337578ANew ZealandA
JP2001524948AJapanA
EP0975349A4European Patent Office (EPO)A4
EP0975349B1European Patent Office (EPO)B1
AT292972TThis recordAustriaT
ATE292972T1AustriaT1
DE69829748D1GermanyD1
DK0975349T3DenmarkT3
PT975349EPortugalE
ES2241124T3SpainT3
KR100530683B1Republic of KoreaB1
DE69829748T2GermanyT2
CA2283071CCanadaC
JP4339411B2JapanB2